Sovaldi generic by Cipla

Recent Articles

• Stada acquired 15 OTC brands of GSK
• Case Study : Rx-to-OTC switch of Voltaren arthritis pain
• Analysis of Business Deal: Collegium Pharma acquired of U.S. Rights to Nucynta Franchise for $375M
• Cipla to acquire four women’s health brands from Wanbury
• Insight on Curis, Aurigene collaboration for development and commercialization of CA-170
• Nestlé, Valbiotis partners to develop & commercialize plant-derived active substance, TOTUM-63 to reduce risk of developing type 2 diabetes
• Strides to acquire 18 ANDAs from Pharmaceutics International
• CODA Biotherapeutics acquired 3 clinical stage assets from Attenua
• How biosimilar priced in US market?
• Pfizer launched Zirabev, Ruxience, Trazimera biosimilar in US
• Merck’s Dificid received USFDA approval for Infections in Children
• EyePoint Pharmaceuticals and Ocumension Therapeutics’s Exclusive License Agreement to Develop and Commercialize DEXYCU
• Helsinn out-licenses Akynzeo and Onicit in Russia to Berlin-Chemie
• Insight on 2019 USFDA New Drug Approval
• Insight on J&J’s TB mass awareness campaign in India
• CUTX-101 of Fortress Biotech gets US FDA rare pediatric disease designation to treat Menkes disease
• What is Edible security tag?
• Acquisition in Pharma: Why Astellas to acquire Xyphos Biosciences?
• US FDA issued CRL to ViiV Healthcare for use of cabotegravir and rilpivirine long-acting regimen for treatment of HIV
• US FDA issues Complete Response Lette to Takeda’s Entyvio for maintenance therapy in adults with ulcerative colitis